Israel vs Mauritania: Treatment success rate for patients treated for MDR-TB
Israel
73.0%
in 2022
Mauritania
73.0%
in 2021
Israel rank
83rd
Mauritania rank
83rd
Treatment success rate for patients treated for MDR-TB over time
- Israel
- Mauritania
How they compare
Israel currently reports 73.0% against 73.0% in Mauritania, a difference of 0.0%.
The two have swapped places 3 times across 14 shared years of data; in 2003 it was Israel ahead.
Israel ranks 83rd and Mauritania ranks 83rd of 163 countries.
Across the 3 decades both report, Israel averaged higher in 2 and Mauritania in 1.
Head to head by decade
| Decade | Israel | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 84.7% | 27.3% | 57.3% | Israel |
| 2010s | 66.1% | 32.7% | 33.4% | Israel |
| 2020s | 67.5% | 74.0% | 6.5% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Israel or Mauritania?
- Israel, at 73.0% against 73.0% in Mauritania as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Israel and Mauritania?
- 0.0%, with Israel ahead.
- How many years of comparable data are there for Israel and Mauritania?
- 14 years are reported by both, from 2003 to 2021.
- How do Israel and Mauritania rank globally for treatment success rate for patients treated for mdr-tb?
- Israel ranks 83rd and Mauritania ranks 83rd of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.